Last reviewed · How we verify

NCT06330259: AMH

Does the AMH Concentration Depend on the Menstrual Cycle?

Completed Last updated 1 April 2024
What this trial tests

trial testing menstrual cycle monitoring in Reproductive Sterility in 50 participants. Completed in 31 December 2019.

Timeline
1 July 2017
Primary endpoint
30 June 2018
31 December 2019

Quick facts

Lead sponsorUniversity of Basel
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 July 2017
Primary completion30 June 2018
Estimated completion31 December 2019
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Basel

Who can join

Adults 18 to 39, female only, with Reproductive Sterility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During two none subsequent natural menstrual cycles healthy female participants will be subjected every second day to blood sampling and 3D-ultrasound examinations. Together with four other key hormones the concentration of AMH (anti-Muellerian Hormone) will be measured in the serum.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Reproductive Sterility

Currently open trials in the same condition.

Other University of Basel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06330259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing